Abstract:BackgroundDiagnosis of monogenic as well as atypical forms of diabetes mellitus has important clinical implications for their specific diagnosis, prognosis, and targeted treatment. Single gene mutations that affect beta-cell function represent 1–2% of all cases of diabetes. However, phenotypic heterogeneity and lack of family history of diabetes can limit the diagnosis of monogenic forms of diabetes. Next-generation sequencing technologies provide an excellent opportunity to screen large numbers of individuals with a diagnosis of diabetes for mutations in disease-associated genes.MethodsWe utilized a targeted sequencing approach using the Illumina HiSeq to perform a case-control sequencing study of 22 monogenic diabetes genes in 4016 individuals with type 2 diabetes (including 1346 individuals diagnosed before the age of 40 years) and 2872 controls. We analyzed protein-coding variants identified from the sequence data and compared the frequencies of pathogenic variants (protein-truncating variants and missense variants) between the cases and controls.ResultsA total of 40 individuals with diabetes (1.8% of early onset sub-group and 0.6% of adult onset sub-group) were carriers of known pathogenic missense variants in the GCK, HNF1A, HNF4A, ABCC8, and INS genes. In addition, heterozygous protein truncating mutations were detected in the GCK, HNF1A, and HNF1B genes in seven individuals with diabetes. Rare missense mutations in the GCK gene were significantly over-represented in individuals with diabetes (0.5% carrier frequency) compared to controls (0.035%). One individual with early onset diabetes was homozygous for a rare pathogenic missense variant in the WFS1 gene but did not have the additional phenotypes associated with Wolfram syndrome.ConclusionTargeted sequencing of genes linked with monogenic diabetes can identify disease-relevant mutations in individuals diagnosed with type 2 diabetes not suspected of having monogenic forms of the disease. Our data suggests that GCK-MODY frequently masquerades as classical type 2 diabetes. The results confirm that MODY is under-diagnosed, particularly in individuals presenting with early onset diabetes and clinically labeled as type 2 diabetes; thus, sequencing of all monogenic diabetes genes should be routinely considered in such individuals. Genetic information can provide a specific diagnosis, inform disease prognosis and may help to better stratify treatment plans.

Monogenic Diabetes: A Comprehensive Overview and Therapeutic Management of Subtypes of Mody

Monogenic diabetes in children: An underdiagnosed and poorly managed clinical dilemma

From Clinical Suspicion to Genetic Diagnosis and Management of Rare Types of Diabetes

Progress of Diagnosis and Treatment for Maturity-Onset Diabetes of the Young

The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY)

Exploring the genetic basis of childhood monogenic diabetes

Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals

Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment

A case series of maturity-onset diabetes of the young highlighting atypical presentations and the implications of genetic diagnosis

Molecular and Clinical Profiles of Pediatric Monogenic Diabetes Subtypes: Comprehensive Genetic Analysis of 138 Patients

Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives

[Clinical characteristics and genetic analysis of children and adolescents with monogenic diabetes]

Genetics and Pathophysiology of Maturity-onset Diabetes of the Young (MODY): A Review of Current Trends

Novel Treatment Options in Patients with Maturity-Onset Diabetes of the Young

Genetic Variants and Therapeutic Approaches in Maturity-Onset Diabetes of the Young: A Retrospective Analysis

Management of monogenic diabetes in pregnancy: A narrative review

Unraveling the genetic basis of MODY: insights from next-generation sequencing

Monogenic Type 2 Diabetes Mellitus and Current Status and Tasks of Its Study in Chinese

From glucose sensing to exocytosis: takes from maturity onset diabetes of the young

Monogenic Diabetes in Youth With Presumed Type 2 Diabetes: Results From the Progress in Diabetes Genetics in Youth (ProDiGY) Collaboration

The newly discovered MODY subtypes